Evidence map›Paper›PMID 42583409›Full record

ArticleCureus2026

Bilateral Mooren's Ulcer With Corneal Perforation in Two Women of Different Ethnicities: A Report of Two Cases.

Alessandra Balestrazzi, Paolo Michieletto, Marzia Michieletto

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alessandra BalestrazziOphthalmology, Azienda Sanitaria Locale (ASL) Roma 2, Rome, ITA.
Paolo MichielettoOphthalmology, Azienda Sanitaria Locale (ASL) Roma 1, Rome, ITA.
Marzia MichielettoOphthalmology, Agostino Gemelli University Polyclinic, Rome, ITA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present two patients with bilateral Mooren's ulcer complicated by corneal perforation and describe their surgical and systemic management. A 55-year-old Caucasian woman (Case 1) and a 55-year-old African woman (Case 2) presented with bilateral Mooren's ulcer. Both had corneal perforation in the right eye and impending perforation in the left eye. Visual acuity in the right eye was reduced due to nasal pupillary displacement and posterior capsular opacification in Case 1 and cataract in Case 2. Both patients had previously undergone a corneal-conjunctival patch procedure in the right eye, but the diagnosis of Mooren's ulcer had not been established prior to referral. Surgical management included lamellar keratoplasty in Case 1 and penetrating keratoplasty with selective conjunctival resection in Case 2. Systemic immunosuppression with mycophenolate mofetil (MMF) was administered in both cases. In Case 1, posterior capsulotomy improved visual acuity to 20/50 with spectacles and to 20/30 with scleral contact lenses. At follow-up, Case 1 showed stability in both eyes, 2 years after lamellar keratoplasty in the right eye and 20 months after conjunctival resection in the left eye. Case 2 had a shorter follow-up, with stability at six months in the right eye and at three months in the left eye. These cases highlight the aggressive bilateral nature of Mooren's ulcer, particularly in the African population, and underscore the importance of individualized surgical and systemic management. Early recognition and combined therapy, including keratoplasty, conjunctival resection, and systemic immunosuppression, can stabilize the disease and optimize visual outcomes despite the initial severe presentation.

Indexed as

case reportconjunctival resectioncorneal perforationkeratoplastymooren’s ulcersystemic immunosuppression

Identifiers

PMID42583409
PMCPMC13460866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.